Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Ellis Sean, Director. Director active across 1 company, notably Entera Bio Ltd.. In total, 11 filings have been recorded. Breakdown: 6 buys · 0 sell. Total volume traded: €116k. History available since 18 January 2022. The latest transaction was disclosed on 7 August 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Ellis Sean
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10,000 shares@ US$2.80521.3% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-22-000163:0
Canonical exit: 18 Apr 2022 (T+90)
11 of 11 declarations
About Ellis Sean
Ellis Sean is a Director at Entera Bio Ltd. In this role, he participates in the governance of the company and strategic decision-making. His experience in the biopharmaceutical sector allows him to make significant contributions to board discussions. He collaborates with other members to ensure the company's compliance and performance.